HSBC sets aside $300 million extra for performance pay and $3 billion for stock buybacks
By Steve Goldstein
HSBC Holdings on Monday said it's earmarking an extra $300 million for performance-related pay, as the bank reported a big surge in third-quarter profit.
CFO Georges Elhedery on a conference call said the board and remuneration committee will ultimately decide, but the planned boost to pay is in recognition of the reshaping of the bank, its strong balance sheet, and the growth in wealth and transaction banking.
HSBC also flagged it would spend about 1% more than previously expected on technology and operations expenditure.
The bank more broadly reported a near tripling of third-quarter profit, to $6.27 billion from $2.66 billion, as revenue rose 40% to $16.16 billion. It benefited from a flattering comparison to last year, when it took a $2.5 billion impairment on its French retail banking operations, and revenue also was helped by the impact of interest rate rises in its payments, global banking and markets and personal banking divisions.
HSBC reversed most of that in the first quarter when the sale became less certain, but now is expecting to reinstate the impairment in the fourth quarter. Expected credit losses were stable at $1.07 billion.
It also announced a $3 billion stock buyback.
HSBC (UK:HSBA) (HSBC) drifted 0.4% lower in U.K. trade. The stock has gained 16% this year.
-Steve Goldstein
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
10-30-23 0733ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth